Aurinia Pharmaceuticals Inc. (AUPH)
USD 9.1
(-4.71%)
USD 9.1
(-4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -33.46 Million | -79.52 Million | -157.69 Million | -69.85 Million | -63.45 Million | -51.61 Million |
| Net Income | -78.02 Million | -108.18 Million | -180.96 Million | -102.68 Million | -123.84 Million | -64.12 Million |
| Depreciation & Amortization | 11.64 Million | 2.7 Million | 2.76 Million | 1.37 Million | 1.54 Million | 1.56 Million |
| Deferred income taxes | -81.68 Million | - | - | - | 41.14 Million | 9.96 Million |
| Stock-based compensation | 45.31 Million | 32.3 Million | 31.24 Million | 17.45 Million | 7.41 Million | 6.86 Million |
| Change in working capital | -5.6 Million | -6.81 Million | -21.63 Million | 4.52 Million | 2.12 Million | -6 Million |
| Other non-cash items | 74.89 Million | 462 Thousand | 10.9 Million | 9.47 Million | 8.15 Million | 118 Thousand |
| Investing Cash Flow | -6.7 Million | -60.63 Million | -103.87 Million | -158.18 Million | 7.78 Million | -66 Thousand |
| Investments in PPE | -718 Thousand | -292 Thousand | -1.5 Million | -7.34 Million | -104 Thousand | -75 Thousand |
| Acquisitions | - | - | -1.2 Million | 1.75 Million | - | 45 Thousand |
| Investment purchases | -523.5 Million | -523.99 Million | -438.95 Million | -202.95 Million | - | -36.08 Million |
| Sales/Maturities of investments | 529.37 Million | 464.31 Million | 354.42 Million | 52.1 Million | 7.88 Million | 36.09 Million |
| Other Investing Activities | -11.86 Million | -663 Thousand | -16.63 Million | -1.75 Million | 7.86 Million | -45 Thousand |
| Financing Cash Flow | -5.13 Million | 2.43 Million | 221.11 Million | 194.37 Million | 243.72 Million | 4.01 Million |
| Debt repayment | -10.02 Million | - | - | - | -127 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 4.89 Million | 2.43 Million | 196.74 Million | 187.73 Million | 223.11 Million | 4.01 Million |
| Other Financing Activities | -10.02 Million | 2.43 Million | 24.37 Million | 6.64 Million | 20.73 Million | 4.01 Million |
| Accounts receivables | -10.6 Million | 1.92 Million | -15.41 Million | -13.62 Million | -151 Thousand | -108 Thousand |
| Accounts payables | 13.39 Million | 699 Thousand | 4.07 Million | 13.62 Million | 4 Million | -888 Thousand |
| Inventory | -15.86 Million | -9.07 Million | -5.64 Million | -13.92 Million | -3.85 Million | - |
| Other working capital | 7.47 Million | -371 Thousand | -4.65 Million | 18.44 Million | 2.12 Million | -6 Million |
| Cash at beginning of period | 94.17 Million | 231.9 Million | 272.35 Million | 306.01 Million | 117.96 Million | 165.62 Million |
| Cash at end of period | 48.87 Million | 94.17 Million | 231.9 Million | 272.35 Million | 306.01 Million | 117.96 Million |
| Capital Expenditure | -718 Thousand | -292 Thousand | -1.5 Million | -7.34 Million | -104 Thousand | -75 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -45.29 Million | -137.72 Million | -40.45 Million | -33.66 Million | 188.05 Million | -47.66 Million |
| Free Cash Flow | -34.17 Million | -79.82 Million | -159.19 Million | -77.2 Million | -63.56 Million | -51.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 722 Thousand | -10.74 Million | -78.02 Million | -26.87 Million | -13.44 Million | -11.49 Million |
| Depreciation & Amortization | 4.84 Million | 4.84 Million | 11.64 Million | 4.94 Million | 5.26 Million | 719 Thousand |
| Deferred income taxes | - | - | -81.68 Million | -12.9 Million | -2.32 Million | -5.59 Million |
| Stock-based compensation | 8.58 Million | 5.73 Million | 45.31 Million | 11.76 Million | 11.8 Million | 12.26 Million |
| Change in working capital | 5.81 Million | -10.76 Million | -5.6 Million | 19.58 Million | -13.9 Million | 2.11 Million |
| Other non-cash items | 2.99 Million | 19.22 Million | 74.89 Million | 18.28 Million | -675 Thousand | -841 Thousand |
| Investing Cash Flow | -38.69 Million | 49.23 Million | -6.7 Million | -6.19 Million | -19.7 Million | -5.6 Million |
| Investments in PPE | -83.32 Thousand | -11.99 Thousand | -718 Thousand | -49.73 Thousand | 105 Thousand | -227 Thousand |
| Acquisitions | - | - | - | 1.00 | - | 50 Thousand |
| Investment purchases | -194.61 Million | -121.26 Million | -523.5 Million | -137.95 Million | -122.77 Million | -114.04 Million |
| Sales/Maturities of investments | 156.04 Million | 170.5 Million | 529.37 Million | 131.65 Million | 102.99 Million | 120.52 Million |
| Other Investing Activities | -43.68 Thousand | 49.23 Million | -11.86 Million | 157.25 Thousand | -28 Thousand | -11.91 Million |
| Financing Cash Flow | -8.1 Million | -15.05 Million | -5.13 Million | -5.53 Million | -2.33 Million | 1.14 Million |
| Debt repayment | -3.22 Million | -2.77 Million | -10.02 Million | -6.54 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -6 Million | -12.3 Million | - | - | - | - |
| Common Stock Issuance | 1.07 Million | 28 Thousand | 4.89 Million | 905.17 Thousand | 1.15 Million | 1.14 Million |
| Other Financing Activities | -3.18 Million | -2.77 Million | -10.02 Million | 105.36 Thousand | -3.48 Million | -9822.00 |
| Accounts receivables | 3.39 Million | -4.82 Million | -10.6 Million | 14.05 Million | -18.44 Million | -457 Thousand |
| Accounts payables | 6.87 Million | -6.59 Million | 13.39 Million | 1.41 Million | 10.56 Million | 5.36 Million |
| Inventory | 901.97 Thousand | -55.99 Thousand | -15.86 Million | -6.7 Million | -581 Thousand | -1.41 Million |
| Other working capital | -5.35 Million | 709 Thousand | 7.47 Million | 10.82 Million | -5.44 Million | -1.37 Million |
| Cash at beginning of period | 64.45 Million | 48.87 Million | 94.17 Million | 46.39 Million | 81.7 Million | 89 Million |
| Cash at end of period | 33.4 Million | 64.45 Million | 48.87 Million | 48.87 Million | 46.39 Million | 81.7 Million |
| Capital Expenditure | -83.32 Thousand | -11.99 Thousand | -718 Thousand | -49.73 Thousand | 105 Thousand | -227 Thousand |
| Effect of forex changes on cash | - | - | - | 5.98 Million | - | - |
| Net cash flow / Change in cash | -31.05 Million | 15.58 Million | -45.29 Million | 2.47 Million | -35.31 Million | -7.29 Million |
| Free Cash Flow | 15.77 Million | -18.6 Million | -34.17 Million | 14.76 Million | -13.17 Million | -3.05 Million |
4323
CAZ
084110
CNLTP
600455
0091